Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.35
-0.22 (-1.51%)
At close: May 27, 2025, 3:59 PM
14.00
-2.44%
After-hours: May 27, 2025, 06:53 PM EDT
-1.51% (1D)
| Bid | 13.6 |
| Market Cap | 582.83M |
| Revenue (ttm) | 214.71M |
| Net Income (ttm) | 4.21M |
| EPS (ttm) | -0.17 |
| PE Ratio (ttm) | -84.41 |
| Forward PE | -3.27 |
| Analyst | Hold |
| Ask | 14.86 |
| Volume | 411,247 |
| Avg. Volume (20D) | 1,037,056 |
| Open | 14.63 |
| Previous Close | 14.57 |
| Day's Range | 14.19 - 14.66 |
| 52-Week Range | 9.12 - 72.37 |
| Beta | 1.32 |
About KROS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KROS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KROS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+18.49%
Keros Therapeutics shares are trading higher. The ...
Unlock content with
Pro Subscription
4 months ago
-16.51%
Keros Therapeutics shares are trading lower after the company announced an update on its Phase 2 TROPOS trial and halted all dosing based on the ongoing safety review.
